Day 2 :
Semmelweis University, Hungary
Time : 10:40-11:20
Anna Tompa is working as a Professor at Semmelweis University Faculty of Medicine 1964-1970 she worked as Assistant Professor in Institute of Pathology and Cancer Research, Anna Worked as Visiting Scientist at Eppley Institute Omaha NE from 1976 to1978, she is a Cheif Scientist during 1979 to 1998 at National Institute of Occupational Health, Presently Anna working as Deputy Director.
Prof: Anna Tompa had a membership in: The International society for Preventive Oncology, European Association of Public Health, Fellow of Collegium Ramazzini, European Association of Oncology, European Association of Mutagenesis.
Cancer is a major disease worldwide among the chronic non-infectious diseases, but there are marked geographic variations in incidence overall. Especially the cancer incidence in Hungary is much higher than in any post-communist country, mainly due to the high incidence of smoking and unhealthy diet. It is the second largest cause of death in our country exceeded only by cardiovascular diseases. In 2016, 64000 new cases of cancer and 33000 cancer deaths (approximately 20% of all deaths) were recorded. According to the WHO statistics 54 million cancer patients were registered in the world in 2016. 14 million new cases are diagnosed annually and more than 8.8 million people die of the disease every year in the world. In some Western countries, cancer mortality rates have recently started to decline, due to a reduction in smoking prevalence, improved early detection and advances in cancer therapy and introducing successful preventive measures. Genotoxicological investigations serve as tools to detect the damages caused by the environmental and occupational mutagens and carcinogens acquired by the somatic cells. These damages are well demonstrated in the course of genotoxicological monitoring by chromosomal mutation, Sister Chromatid Exchange (SCE) and the blastic transformation activity of Peripheral Blood Lymphocytes (PBL), among workers who were exposed to chemical carcinogens. In our genotoxicological monitoring system, we have investigated more than 8000 individual exposed to different carcinogens, cytostatic drugs, industrial solvents, formaldehyde, heavy metals,
styrene, 1-3-butadiene, etc. These studies showed an elevation of chromosomal aberrations, sister chromatid-exchanges and reduced DNA-repair capacity. The main point of intervention was the improvement of the work-sites including lowering the exposure and convincing the workers to change their life styles avoiding confounding factors, e.g. drugs, alcohol, medication and smoking. This monitoring system was also used to determine the protective effects of some natural products with known antioxidant capacity against the genotoxic effects of these pollutants in vivo. In the case of heavy metal (precious metals, chromium, cadmium and nickel) exposed workers, after a chemoprevention treatment with the nutritional supplement Humetta® containing various antioxidants and chelating agents, results showed a decrease in genotoxic effects, together with improved health status based in the clinical laboratory data.
Cleveland Clinic Abu Dhabi, UAE
Time : 10:00-10:40
Lorraine has been a perioperative nurse for over 27 years and has worked on all three coasts of Canada. She has fulfilled multiple nursing roles throughout her career and has presented at both national and international conferences on various topics for the Perioperative Environement. This is her first experience working in another country.
This presentation will share the lessons learned; the success and challenges experienced by the Cleveland Clinic Abu Dhabi (CCAD) Perioperative Leadership team in uniting 15 different nationalities and cultures into one cohesive, high performing patient care team.
CCAD is the first Academic Medical & Research Centre in the UAE. A total of 75 different nationalities comprise the caregiver population at CCAD. With 15 different languages and the accompanying accents, misunderstandings through verbal communication and body language, is a constant hazard.
CCAD has been open to patient care since February 2015 and within this ‘start-up’ environment, change is the common theme on all levels throughout the organization. A primary goal for the perioperative team is harnessing the experience, knowledge and enthusiasm of so many different caregivers and channeling it into one consistent way of caring for our patients and families. Adding to the complexity of working with a multinational group, is the intricacy of providing care for the unique and multifaceted Emerati culture. These amazing people are our patients, families and co-workers and willingly share their world with us every day
Creating and implementing the CCAD way through evidence based practice, AORN Guidelines, Hospital Policy, Unit Based Practice Councils and Education, we continue to grow into ourselves, building our future and striving for excellence in our care..